Patents Assigned to Theranostics Laboratory
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20140206716
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: January 8, 2014
    Publication date: July 24, 2014
    Applicant: Theranostics Laboratory
    Inventors: Patrick A. Gladding, Marja-Liisa Dahl, Mark W. Webster
  • Methods for the assessment of drug response
    Patent number: 8084210
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent. Nucleotide probes and primers, kits, and microarrays suitable for such assessment are also provided.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: December 27, 2011
    Assignee: Theranostics Laboratory
    Inventors: Patrick A. Gladding, Arzu Gunes, Marja-Liisa Dahl, Mark W. Webster
  • METHODS AND COMPOSITIONS FOR THE ASSESSMENT OF DRUG RESPONSE
    Publication number: 20110060532
    Abstract: The present invention provides methods for predicting or determining a subject's response to an antiplatelet agent, and methods for determining a subject's suitability to a treatment regime or intervention for a disease associated with platelet aggregation, using analysis of genetic polymorphisms. The present invention also relates to the use of genetic polymorphisms in assessing a subject's response to an antiplatelet agent.
    Type: Application
    Filed: November 19, 2010
    Publication date: March 10, 2011
    Applicant: THERANOSTICS LABORATORY
    Inventors: Patrick A. Gladding, Arzu Gunes, Marja-Liisa Dahl, Mark W. Webster